MEDICAMEN BIOTECH LIMITED
MEDICAMEQ · General/Diversified · NSE
₹270
Current Market Price
Under Review— We don’t have enough data to publish a fair value estimate for MEDICAMEQ yet. Reason: Data Limited.
Updated just now
YieldIQ Score
—
Piotroski F-Score
4/9
Economic Moat
None
Confidence
31%
ROE
3.4%
Debt/Equity
0.16
WACC
11.1%
Market Cap
₹365.59 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
8.2%
Return on capital employed
EV / EBITDA
25.6×
Enterprise multiple
Debt / EBITDA
2.5×
Leverage vs earnings
Interest Coverage
4.1×
EBIT covers interest
Current Ratio
2.11×
Short-term liquidity
Asset Turnover
0.56×
Revenue per ₹ of assets
Revenue CAGR (3Y)
12.0%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
Ratio Trends
MEDICAMEQ · last 4 annual periods
ROE
3.4%
ROCE
8.2%
Operating Margin
—
Debt / Equity
0.16×
PE
60.2×
EV / EBITDA
34.1×
Historical Financials
MEDICAMEQ · Annual, last 4 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | CAGR |
|---|---|---|---|---|---|
| Revenue | ₹115 Cr | ₹141 Cr | ₹179 Cr | ₹163 Cr | +12.1% |
| EBITDA | ₹25.3 Cr | ₹26.3 Cr | ₹24.6 Cr | ₹20.1 Cr | -7.3% |
| EBIT | ₹19.5 Cr | ₹20.0 Cr | ₹17.5 Cr | — | -3.6% |
| PAT | ₹14.9 Cr | ₹14.8 Cr | ₹10.9 Cr | ₹7.1 Cr | -21.9% |
| EPS (diluted) | ₹12.19 | ₹11.82 | ₹7.50 | — | -14.9% |
| CFO | ₹4.1 Cr | ₹-6.3 Cr | ₹-6.7 Cr | ₹-8.2 Cr | — |
| CapEx | ₹-8.6 Cr | ₹-6.6 Cr | ₹-6.3 Cr | ₹-2.2 Cr | — |
| FCF | ₹-4.5 Cr | ₹-12.9 Cr | ₹-13.0 Cr | ₹-10.3 Cr | — |
| Total Assets | ₹226 Cr | ₹279 Cr | ₹295 Cr | ₹297 Cr | +9.6% |
| Total Debt | ₹25.8 Cr | ₹25.7 Cr | ₹31.1 Cr | ₹33.8 Cr | +9.4% |
| Shareholders' Equity | ₹146 Cr | ₹193 Cr | ₹205 Cr | ₹212 Cr | +13.1% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
MEDICAMEQ vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
MEDICO MEDICO | — | — | Pending | 17.4% | — |
BAFNAPH BAFNAPH | — | — | Pending | 4.9% | — |
VALIANTLAB VALIANTLAB | — | — | Pending | -0.9% | — |
ALBERTDAVD ALBERTDAVD | — | — | Pending | -0.4% | — |
ZIMLAB ZIMLAB | — | — | Pending | 4.8% | — |
Click a ticker to view its fair-value analysis.
Dividend History
4 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹4.00/sh
Last payout
2025-09-19
₹1.00
Peak payout
₹1.00
Trailing yield
0.37%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
Risk Analysis
Volatility & drawdown
Risk profile of MEDICAMEQ →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for MEDICAMEQ →
Compare
Head-to-head with peers
Compare MEDICAMEQ side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse MEDICAMEQNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.